WallStreetZenWallStreetZen

NASDAQ: LIMN
Liminatus Pharma Revenue

OverviewEarningsRevenue
DividendOwnership
Liminatus Pharma revenue was N/A for the trailing 12 months ending Mar 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2024) ending on Mar 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LIMN annual revenue was $0.0, with N/A growth year-over-year.

LIMN revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when LIMN announces revenue.

LIMN Revenue History By Year

LIMN Yearly RevenueLIMN RevenueLIMN ChangeLIMN Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Liminatus Pharma Revenue FAQ

What was LIMN's revenue last quarter?

Liminatus Pharma (NASDAQ: LIMN) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Liminatus Pharma's revenue was $0.00.

What was Liminatus Pharma's revenue in 2023?

Liminatus Pharma's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Liminatus Pharma make in a day?

Based on Liminatus Pharma annual revenue for the past one years, LIMN makes an average of $0.00 per day.

What was Liminatus Pharma's annual revenue growth in the past year?

As of Q2 2025, Liminatus Pharma's revenue has grown null year over year. Liminatus Pharma's revenue in the past year totaled N/A.

How much does Liminatus Pharma make in a year?

Liminatus Pharma's revenue by year for the past one years is:
  • Liminatus Pharma's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.